Cardiff Lexington Corp CDIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CDIX is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $5.00
- Day Range
- $3.25–3.25
- 52-Week Range
- $0.00–105.00
- Bid/Ask
- $0.02 / $5.00
- Market Cap
- $35.43 Mil
- Volume/Avg
- 2,444 / 418
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.18
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cardiff Lexington Corp is an acquisition holding company focused on locating undervalued and undercapitalized companies, primarily in the healthcare industry, and providing them capitalization and leadership to maximize the value and potential of their private enterprises while also providing diversification and risk mitigation for its stockholders. It has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The healthcare segment provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The real estate segment consists of Edge View, a real estate company that owns five (5) acres zoned medium-density residential.
- Sector
- Financial Services
- Industry
- Asset Management
- Stock Style Box
- —
- Total Number of Employees
- 13
- Website
- https://www.cardifflexington.com
Valuation
|
Metric
|
CDIX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.18 |
Price/Cash Flow | — |
Price/Earnings
CDIX
Financial Strength
|
Metric
|
CDIX
|
|---|---|
Quick Ratio | 1.02 |
Current Ratio | 1.02 |
Interest Coverage | 2.49 |
Quick Ratio
CDIX
Profitability
|
Metric
|
CDIX
|
|---|---|
Return on Assets (Normalized) | 18.23% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 87.06% |
Return on Assets
CDIX
Asset Management Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
BLK
| BlackRock Inc | Ttvykcmmr | Vdmn | $112.7 Bil | |
BX
| Blackstone Inc | Bkhrkpz | Dkvdl | $93.7 Bil | |
KKR
| KKR & Co Inc Ordinary Shares | Qdbbqjknb | Tlcggm | $85.6 Bil | |
BK
| Bank of New York Mellon Corp | Zhljxzxy | Yfc | $42.8 Bil | |
AMP
| Ameriprise Financial Inc | Jywrdzyz | Qkgvtz | $41.4 Bil | |
TROW
| T. Rowe Price Group Inc | Gjmjpdbvm | Pcw | $24.3 Bil | |
STT
| State Street Corporation | Rbyqfnzv | Qncy | $22.4 Bil | |
NTRS
| Northern Trust Corp | Hpnblwpt | Hcq | $17.2 Bil | |
CG
| The Carlyle Group Inc | Nnzblnsg | Fjmmw | $16.6 Bil | |
BEN
| Franklin Resources Inc | Lnvrtddtcg | Tghsmb | $13.2 Bil |